Loading…

GSK inaugurated a new €30 million, 1,500 m² plant at its San Polo di Torrile site in Parma, Italy, for production and packaging of fostemsavir, an HIV drug for heavily treatment-experienced patients.
“Inaugurato oggi un nuovo impianto di 1.500 m² nello stabilimento GSK di San Polo di Torrile a Parma.”it.gsk.com
Summarized from public sources; check the original articles before acting on it.